AI Article Synopsis
- This case study examines GP Shared Care as a valuable model for enhancing healthcare collaboration amid the challenges posed by COVID-19.
- It highlights the potential for developing stronger partnerships between healthcare providers to improve patient care.
- The insights gained from this case study can inform future strategies for addressing similar healthcare crises.
Article Abstract
This case study of GP Shared Care provides an interesting lens though which to view the current opportunities for improved healthcare partnerships as we respond to the COVID-19 challenges.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.31128/AJGP-COVID-37 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ebola disease: bridging scientific discoveries and clinical application.
Lancet Infect Dis
December 2024
Pandemic Sciences Institute, Oxford, UK.
The west Africa Ebola disease epidemic (2014-16) marked a historic change of course for patient care during emerging infectious disease outbreaks. The epidemic response was a failure in many ways-a slow, cumbersome, and disjointed effort by a global architecture that was not fit for purpose for a rapidly spreading outbreak. In the most affected countries, health-care workers and other responders felt helpless-dealing with an overwhelming number of patients but with few, if any, tools at their disposal to provide high-quality care.
View Article and Find Full Text PDFUbiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L.
EMBO Rep
October 2024
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
The recent discovery of non-proteinaceous ubiquitylation substrates broadened our understanding of this modification beyond conventional protein targets. However, the existence of additional types of substrates remains elusive. Here, we present evidence that nucleic acids can also be directly ubiquitylated via ester bond formation.
View Article and Find Full Text PDFDifferential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.
Med
February 2022
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.
Background: Protection offered by coronavirus disease 2019 (COVID-19) vaccines wanes over time, requiring an evaluation of different boosting strategies to revert such a trend and enhance the quantity and quality of Spike-specific humoral and cellular immune responses. These immunological parameters in homologous or heterologous vaccination boosts have thus far been studied for mRNA and ChAdOx1 nCoV-19 vaccines, but knowledge on individuals who received a single dose of Ad26.COV2.
View Article and Find Full Text PDFCOVID-19: Pump-priming positive healthcare reform.
Aust J Gen Pract
September 2020
PhD, MBA, GradDipPhty, GAICD, Deputy Director, Centre for Health System Reform @ Integration, Mater Research Institute @ University of Queensland, Qld; Director, Care Innovation Centre, Mater Misericordiae Ltd, Qld; Honorary Senior Lecturer, Primary Care Clinical Unit, Faculty of Medicine, University of Queensland, Qld.
Article Synopsis
- This case study examines GP Shared Care as a valuable model for enhancing healthcare collaboration amid the challenges posed by COVID-19.
- It highlights the potential for developing stronger partnerships between healthcare providers to improve patient care.
- The insights gained from this case study can inform future strategies for addressing similar healthcare crises.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!